Vijay Kumar Kuchroo
Director/Board Member at SYNGENE INTERNATIONAL LIMITED
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Peter Bains | M | 65 | 10 years | |
| Kiran Mazumdar-Shaw | F | 71 |
Bicara Therapeutics, Inc.
 Bicara Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bicara Therapeutics, Inc. is a company that develops first-in-class bifunctional antibodies for the treatment of solid tumors. The company is based in Cambridge, MA. The company's lead product candidate, bca101, is a first-in-class egfr/tgf-?-trap bifunctional antibody in clinical development for multiple tumor types. The company's bifunctional antibodies are designed to deliver an immunomodulatory payload directly to the tumor microenvironment to ramp up immune cell activity, offering the potential for synergistic therapeutic impact at the site of the tumor. Bicara has a deep pipeline of promising bifunctional antibodies and other biologics for treating solid tumors. The CEO of the company is Claire Mazumdar.
Massachusetts Institute of Technology
| 30 years |
| Ramnik Xavier | M | 62 |
Celsius Therapeutics, Inc.
 Celsius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Celsius Therapeutics, Inc. translates single-cell genomic insights into precision therapeutics for autoimmune diseases and cancer. The company was founded by Jeffrey A. Bluestone, Vijay K. Kuchroo, Christoph S. Lengauer, Aviv Regev and Ramnik Xavier in 2018 and is headquartered in Boston, MA.
The Broad Institute, Inc.
 The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA.
Harvard Medical School
Massachusetts Institute of Technology
| 11 years |
| David Scadden | M | 71 |
The Broad Institute, Inc.
The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA.
Harvard Medical School
Massachusetts Institute of Technology
| - |
| Eric S. Lander | M | 67 |
Harvard Medical School
Massachusetts Institute of Technology
| 34 years |
| Alexis Borisy | M | 52 |
Celsius Therapeutics, Inc.
Celsius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Celsius Therapeutics, Inc. translates single-cell genomic insights into precision therapeutics for autoimmune diseases and cancer. The company was founded by Jeffrey A. Bluestone, Vijay K. Kuchroo, Christoph S. Lengauer, Aviv Regev and Ramnik Xavier in 2018 and is headquartered in Boston, MA. | - |
| Allan Seymour Bufferd | - | - |
Massachusetts Institute of Technology
| 52 years |
| Charles Cooney | M | 80 |
Massachusetts Institute of Technology
| 54 years |
| Priyadarshini I. Mahapatra | F | - | 5 years | |
| Leo Rafael Reif | M | 73 |
The Broad Institute, Inc.
The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA.
Massachusetts Institute of Technology
| 25 years |
| Claire Mazumdar | M | - |
Bicara Therapeutics, Inc.
Bicara Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bicara Therapeutics, Inc. is a company that develops first-in-class bifunctional antibodies for the treatment of solid tumors. The company is based in Cambridge, MA. The company's lead product candidate, bca101, is a first-in-class egfr/tgf-?-trap bifunctional antibody in clinical development for multiple tumor types. The company's bifunctional antibodies are designed to deliver an immunomodulatory payload directly to the tumor microenvironment to ramp up immune cell activity, offering the potential for synergistic therapeutic impact at the site of the tumor. Bicara has a deep pipeline of promising bifunctional antibodies and other biologics for treating solid tumors. The CEO of the company is Claire Mazumdar. | - |
| Drew Pardoll | M | - |
Potenza Therapeutics, Inc.
 Potenza Therapeutics, Inc. BiotechnologyHealth Technology Potenza Therapeutics, Inc. develops oncology programs and mechanisms for tumors detection. It is focusing on the discovery and development of novel immune-oncology therapeutics: molecules that stimulate the power of the immune system to fight cancer. The company was founded by Drew M. Pardoll and Daniel J. Hicklin in 2014 and is headquartered in Cambridge, MA. | 10 years |
| Vinita Kundanlal Bali | F | 67 | 7 years | |
| Bobby Kanubhai Parikh | M | 60 | 6 years | |
| Steven Hyman | M | 71 |
The Broad Institute, Inc.
The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA.
Massachusetts Institute of Technology
| 12 years |
| Anita Jones | M | 82 |
Massachusetts Institute of Technology
| - |
| Damodaran Meleveetil | M | 77 | 8 years | |
| Jonathan Hunt | M | 55 | 9 years | |
| James Collins | M | 58 |
The Broad Institute, Inc.
The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA.
Massachusetts Institute of Technology
| 10 years |
| Alan Spoon | M | 72 |
Massachusetts Institute of Technology
| - |
| Merit Cudkowicz | M | 61 |
Harvard Medical School
| - |
| Naina Lal Kidwai | F | 67 | 2 years | |
| Kush Parmar | M | 42 | 3 years | |
| Joseph F. Coughlin | M | 60 |
Massachusetts Institute of Technology
| 25 years |
| Kasper Lage | M | - |
Harvard Medical School
Massachusetts Institute of Technology
| - |
| Paul Blackburn | M | 70 | 10 years | |
| William R. Sellers | M | 63 |
Harvard Medical School
Massachusetts Institute of Technology
| - |
| Akhilesh Nand | M | - | 6 years | |
| Jesse Souweine | F | - |
The Broad Institute, Inc.
The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA. | - |
| Marcela Maus | M | 48 |
Harvard Medical School
Massachusetts Institute of Technology
| - |
| Sharmila Abhay Karve | F | 59 | 5 years | |
| Li-Huei Tsai | M | 64 |
The Broad Institute, Inc.
The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA.
Massachusetts Institute of Technology
| - |
| Cigall Kadoch | M | 39 |
Harvard Medical School
Massachusetts Institute of Technology
| 10 years |
| Rekha Mehrotra Menon | M | - | 1 years | |
| Emery Brown | M | 67 |
Harvard Medical School
Massachusetts Institute of Technology
| - |
| Glen L. Urban | M | - |
Massachusetts Institute of Technology
| 58 years |
| Afarin Bellisario | F | - |
Massachusetts Institute of Technology
| 8 years |
| Subramanian V. Ramadorai | M | 76 |
Massachusetts Institute of Technology
| - |
| Mun Tak Yang | F | 70 |
Massachusetts Institute of Technology
| 23 years |
| Arthur Levinson | M | 73 |
The Broad Institute, Inc.
The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA.
Massachusetts Institute of Technology
| 15 years |
| William Gerald Austen | M | 94 |
Harvard Medical School
Massachusetts Institute of Technology
| 50 years |
| Christopher K. McLeod | M | - |
Massachusetts Institute of Technology
| - |
| Robert Millard | M | 73 |
Massachusetts Institute of Technology
| 21 years |
| Norman E. Gaut | M | - |
Massachusetts Institute of Technology
| - |
| Phillip Sharp | M | 79 |
The Broad Institute, Inc.
The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA.
Massachusetts Institute of Technology
| 50 years |
| Ronald Williams | M | 74 |
Massachusetts Institute of Technology
| - |
| Bill Helman | M | 65 |
The Broad Institute, Inc.
The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA.
Harvard Medical School
| - |
| Gerald J. Burnett | M | 81 |
Massachusetts Institute of Technology
| - |
| Tariq Kassum | M | - |
Celsius Therapeutics, Inc.
Celsius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Celsius Therapeutics, Inc. translates single-cell genomic insights into precision therapeutics for autoimmune diseases and cancer. The company was founded by Jeffrey A. Bluestone, Vijay K. Kuchroo, Christoph S. Lengauer, Aviv Regev and Ramnik Xavier in 2018 and is headquartered in Boston, MA. | 5 years |
| Diane Greene | F | 69 |
Massachusetts Institute of Technology
| - |
| Luke Evnin | M | 60 |
Potenza Therapeutics, Inc.
Potenza Therapeutics, Inc. BiotechnologyHealth Technology Potenza Therapeutics, Inc. develops oncology programs and mechanisms for tumors detection. It is focusing on the discovery and development of novel immune-oncology therapeutics: molecules that stimulate the power of the immune system to fight cancer. The company was founded by Drew M. Pardoll and Daniel J. Hicklin in 2014 and is headquartered in Cambridge, MA. | - |
| Susan Hockfield | M | 73 |
Massachusetts Institute of Technology
| 20 years |
| Eric Schmidt | M | 68 |
The Broad Institute, Inc.
The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA. | 12 years |
| R. Gregory Morgan | M | 70 |
Massachusetts Institute of Technology
| - |
| Laura Tyson | M | 76 |
Massachusetts Institute of Technology
| - |
| Kent Summers | M | 65 |
Massachusetts Institute of Technology
| - |
| Anthony Sun | M | 71 |
Massachusetts Institute of Technology
| - |
| Arnold R. Weber | M | 94 |
Massachusetts Institute of Technology
| - |
| Annette Clayton | F | 59 |
Massachusetts Institute of Technology
| - |
| Judy Lewent | F | 75 |
Massachusetts Institute of Technology
| - |
| Shari Loessberg | F | 63 |
Massachusetts Institute of Technology
| 25 years |
| Edward H. Adelson | M | - |
Massachusetts Institute of Technology
| - |
| Assaf Biderman | M | - |
Massachusetts Institute of Technology
| - |
| Darrell J. Irvine | M | - |
Massachusetts Institute of Technology
| - |
| William McClayton | M | 80 |
Massachusetts Institute of Technology
| - |
| John F. Rockart | M | 92 |
Massachusetts Institute of Technology
| 42 years |
| Richard M. Wiesman | M | - |
Massachusetts Institute of Technology
| - |
| Frank Wilczek | M | - |
Massachusetts Institute of Technology
| - |
| Tiffany Shlain | F | 54 |
Massachusetts Institute of Technology
| - |
| Lawrence K. Fish | M | 79 |
Massachusetts Institute of Technology
| - |
| Frans Kaashoek | M | - |
Massachusetts Institute of Technology
| - |
| Robert Langer | M | 74 |
Massachusetts Institute of Technology
| 19 years |
| Randy Cohen | M | - |
Massachusetts Institute of Technology
| - |
| Silvio Micali | M | - |
Massachusetts Institute of Technology
| - |
| Richard Young | M | 70 |
Massachusetts Institute of Technology
| 40 years |
| Lars Olof Sture Lindgren | M | 69 |
Massachusetts Institute of Technology
| - |
| David Page | M | 67 |
Massachusetts Institute of Technology
| - |
| Gregory R. Walton | M | - |
Massachusetts Institute of Technology
| - |
| Angela Belcher | M | - |
Massachusetts Institute of Technology
| - |
| Lorna J. Gibson | M | - |
Massachusetts Institute of Technology
| - |
| Richard Lim | M | 52 |
Massachusetts Institute of Technology
| - |
| Gilbert L. Phillips | M | - |
Massachusetts Institute of Technology
| - |
| Jennifer Yang | F | - |
Massachusetts Institute of Technology
| - |
| Gary Burchill | M | - |
Massachusetts Institute of Technology
| - |
| Abigail Johnson | F | 62 |
Massachusetts Institute of Technology
| - |
| Henning Richter | M | - |
Massachusetts Institute of Technology
| - |
| David L. Brock | M | - |
Massachusetts Institute of Technology
| - |
| Eugene A. Fitzgerald | M | - |
Massachusetts Institute of Technology
| - |
| Sheila E. Widnall | M | 85 |
Massachusetts Institute of Technology
| 26 years |
| Muriel Medard | F | - |
Massachusetts Institute of Technology
| - |
| Susanna E. Bennett | F | - |
Massachusetts Institute of Technology
| - |
| I. P. S. Anand | M | - |
Massachusetts Institute of Technology
| - |
| Wai To Zue | M | 77 |
Massachusetts Institute of Technology
| - |
| Horace Deets | M | - |
Massachusetts Institute of Technology
| - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Bala S. Manian | M | 77 | 16 years | |
| John Russell Fotheringham Walls | M | 80 | 8 years | |
| Suresh Narasappa Talwar | M | 86 | 16 years | |
| Arun Suresh Chandavarkar | M | 62 | 29 years | |
| Christoph S. Lengauer | M | 59 |
Celsius Therapeutics, Inc.
Celsius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Celsius Therapeutics, Inc. translates single-cell genomic insights into precision therapeutics for autoimmune diseases and cancer. The company was founded by Jeffrey A. Bluestone, Vijay K. Kuchroo, Christoph S. Lengauer, Aviv Regev and Ramnik Xavier in 2018 and is headquartered in Boston, MA. | 2 years |
| Mayank Verma | M | - | 7 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 83 | 83.00% |
| India | 19 | 19.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Vijay Kumar Kuchroo
- Personal Network
